These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27565913)
1. Serum mass profile signature as a biomarker of early lung cancer. Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913 [TBL] [Abstract][Full Text] [Related]
2. Serum lipid profile discriminates patients with early lung cancer from healthy controls. Ros-Mazurczyk M; Jelonek K; Marczyk M; Binczyk F; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P Lung Cancer; 2017 Oct; 112():69-74. PubMed ID: 29191603 [TBL] [Abstract][Full Text] [Related]
3. Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study. Roś-Mazurczyk M; Wojakowska A; Marczak Ł; Polański K; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P Acta Biochim Pol; 2017; 64(3):513-518. PubMed ID: 28803255 [TBL] [Abstract][Full Text] [Related]
4. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea. Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219 [TBL] [Abstract][Full Text] [Related]
5. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry. Shevchenko VE; Arnotskaya NE; Zaridze DG Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823 [TBL] [Abstract][Full Text] [Related]
7. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
8. Importance of serum SELDI-TOF-MS analysis in the diagnosis of early lung cancer. Simsek C; Sonmez O; Keyf AI; Yurdakul AS; Ozturk C; Gulbahar O; Ozmen F; Zengin N; Kubilay D; Karatayli SC; Bozdayi M Asian Pac J Cancer Prev; 2013; 14(3):2037-42. PubMed ID: 23679315 [TBL] [Abstract][Full Text] [Related]
9. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer. Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199 [TBL] [Abstract][Full Text] [Related]
11. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432 [TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898 [TBL] [Abstract][Full Text] [Related]
13. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer. Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990 [TBL] [Abstract][Full Text] [Related]
14. Identification of a 17-protein signature in the serum of lung cancer patients. Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer. Wang DB; Lu XK; Zhang X; Li ZG; Li CX Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327 [TBL] [Abstract][Full Text] [Related]
16. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350 [TBL] [Abstract][Full Text] [Related]
18. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
19. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655 [TBL] [Abstract][Full Text] [Related]
20. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]